Expert analyst Patrick Trucchio has spent many years researching the psychedelic drug stock sector. Patrick Trucchio, CFA, is a Managing Director of Equity Research at H.C. Wainwright & Co. whose ...

Tiago Reis Marques, M.D., Ph.D. is the Chief Executive Officer of Pasithea Therapeutics Corp. Dr. Marques is a fellow at Imperial College London and a lecturer at the Institute of Psychiatry, King ...

So, it’s been a few years since you last spoke with The Wall Street Transcript. Let’s start with a refresher about the company and its history and how it’s evolved over the years. Mr. Groesbeck: I’ll ...

Robert Beasley is the CEO of Cansortium Inc. A native Floridian, he co-founded the law firm of Litvak Beasley Wilson & Ball in 2001. As a consultant, Mr. Beasley has advised multiple parties to ...

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Barbara Sher is the CEO of Greenlane Holdings, Inc. Ms. Sher brings over 20 years of experience in senior executive roles at both large and small and public and private companies. She has served ...

Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF) Ahmad Doroudian Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF) Robert Beasley Interview with the CEO: Greenlane Holdings ...

Ahmad Doroudian, Ph.D., is Chief Executive Officer and Director of BetterLife Pharma Inc. Dr. Doroudian is an accomplished executive with over 25 years’ experience in management and development ...

Please introduce your firm, your role, and what you cover in terms of the psychedelics market. Mr. Trucchio: I work at H.C. Wainwright, an investment bank headquartered in New York, as a senior health ...